TOP 10 COMPANIES IN PHARMACEUTICAL PACKAGING MARKET

The Pharmaceutical Packaging Market is projected to reach $176.54 billion by 2031, at a CAGR of 7.6% during the forecast period, says Meticulous Research^®. Pharmaceutical packaging is used as a protective cover to enclose drugs or pharmaceutical preparations. It involves the use of appropriate materials or containers for storing and distributing pharmaceutical preparations. Pharmaceutical packaging includes primary, secondary, and tertiary packaging. Primary pharmaceutical packaging consists of containers and materials that directly contact the drug product or medicine. Secondary and tertiary packaging acts as a protective covering around the pharmaceutical packaging.

The growth of the pharmaceutical packaging market is driven by growth in the pharmaceutical sector, the rising demand for drug delivery devices, growing healthcare expenditures, the increasing focus on biosimilars, the growing trend of contract manufacturing & packaging in the pharmaceutical sector, and growth in the aging population & the consequent rise in chronic disease prevalence. However, increasing instances of counterfeit packaging, increasing waste generation due to single-use packaging, and concerns over certain materials leaching into pharmaceutical preparations restrain the growth of this market.

Furthermore, the rising adoption of personalized medicines & self-medication, improving healthcare provisions in emerging economies, the growth in pharmaceutical R&D spending, and the increasing focus on vaccine development & vaccination coverage are expected to generate growth opportunities for the players operating in this market. However, changing regulatory regimes and changing market demands in the constantly evolving pharmaceutical landscape are major challenges impacting market growth.

Here are the top 10 companies operating in the Pharmaceutical Packaging Market

Amcor plc (Switzerland)

Founded in 1860 and headquartered in Zurich, Switzerland, Amcor plc develops and produces packaging solutions for pharmaceutical, food, medical, and personal care products. The company operates through two reportable segments, namely Flexibles and Rigid Packaging. The company operates in the pharmaceutical packaging market through both these segments. The company’s market segments are categorized into Specialty Cartons, Personal Care, Pet Care, Home Care, Healthcare, Beverages, Food, and Technical Applications. It offers pharmaceutical packaging solutions for injectables, oral, dermal, IV fluids, hospital packaging, medical devices, pulmonary, and ophthalmic & vision care through the Healthcare segment.

The company has a geographical presence in more than 41 countries, including the U.S., Argentina, Italy, Spain, India, Thailand, and South Africa, and approximately 218 sites across the globe. Some of the company’s subsidiaries are Amcor Packaging (U.S.A), Inc. (U.S.), Containers Packaging (Europe) (U.K.), Amcor Flexibles Inc (U.S.), Amcor Pty Ltd (Australia), Amcor France SAS (France), Amcor Group GmbH (Switzerland), Bemis Packaging Inc. (U.S.), Containers Packaging (Europe) (U.K.), and Amcor Rigid Packaging USA LLC (U.S.).

AptarGroup, Inc. (U.S.)

Founded in 1940 and headquartered in Illinois, U.S., AptarGroup, Inc. designs and manufactures drug and consumer product dosing, dispensing, and protection technologies. The company operates through three business segments, namely, Aptar Pharma, Aptar Beauty, and Aptar Closures. The company offers pharmaceutical packaging products through the Aptar Pharma segment. The Aptar Pharma segment is further sub-segmented into five product categories, namely, Prescription Drug, Consumer Health Care, Injectables, Active Material Science Solutions, and Digital Health Solutions.

The company has 22 manufacturing facilities for Aptar Pharma & Closures and 27 manufacturing facilities for Aptar Beauty. It has sales locations in 20 countries, including China, France, Argentina, Spain, Italy, Germany, and other countries.

Some of the company’s subsidiaries are AptarGroup International Holding S.a.r.l. (Luxemburg), Aptargroup UK Holdings Limited (U.K.), Aptar Middle East DMCC (UAE), Aptar Suzhou Dispensing Systems Co. Ltd. (China), Aptar Pharma India Private Limited (India), AptarGroup International L.L.C. (U.S.), Aptar GmbH (Germany), Pfeiffer U.K. Limited (U.K.), AptarGroup S.A.S. (France), and Novares S.p.A. (Italy).

Becton, Dickinson and Company (U.S.)

Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson and Company is a medical technology firm engaged in developing, manufacturing, and selling various medical devices, supplies, laboratory equipment, and diagnostic products. The company offers its products to healthcare institutions, life science researchers, physicians, clinics, diagnostic laboratories, and the pharmaceutical industry.

BD operates through three reportable business segments: BD Medical, BD Life Sciences, and BD Interventional. The company operates in the pharmaceutical packaging market through the BD Medical segment.

The company has manufacturing facilities outside the U.S. in Bosnia and Herzegovina, Brazil, Canada, China, Dominican Republic, France, Germany, Hungary, India, Ireland, Italy, Japan, Mexico, the Netherlands, Singapore, Spain, and the U.K. Its subsidiaries include Becton Dickinson Canada Inc., Becton Dickinson GmbH (Germany), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), Becton Dickinson Asia Limited (Hong Kong), Becton, Dickinson B.V. (Netherlands), and Becton Dickinson India Private Limited (India).

Gerresheimer AG (Germany)

Founded in 1864 and headquartered in Düsseldorf, Germany, Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions for pharma, health, and biotech companies. The company’s product portfolio includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors, and inhalers, as well as vials, ampoules, tablet containers, infusion, dropper, and syrup bottles. The company operates through three divisions, namely, Plastics & Devices, Primary Packaging Glass, and Advanced Technologies.

The company operates in the pharmaceutical packaging market through these three divisions. The company is also involved in the development of connected medical devices and smart services. The company has a geographical presence in Brazil, Belgium, India, China, Denmark, France, Mexico, Switzerland, Spain, and the U.S. Some of the company’s subsidiaries are Gerresheimer Lohr GmbH (Germany), Gerresheimer Momignies SA (Belgium), Gerresheimer Sistemas Plasticos Medicinais São Paulo Ltda. (Brazil), Gerresheimer Plastic Packaging (Changzhou) Co., Ltd. (China), Gerresheimer Bünde GmbH (Germany), and Centor Inc. (U.S.).

Corning Inc. (U.S.)

Founded in 1851 and headquartered in Massachusetts, U.S., Corning Inc. manufactures its products using glass science, ceramic science, and optical physics. The company operates in the semiconductor, optical communications, mobile consumer electronics, display, automotive, solar, and life sciences markets.

The company operates through five reportable segments: Environmental Technologies, Optical Communication, Specialty Materials, Life Sciences, and Display Technologies. The company provides pharmaceutical packaging products through the Life Sciences segment. The life sciences segment provides products for chemicals, drugs, biologics, vaccines, and cell and gene therapies.

Corning Inc. has its production sites for the Life sciences segment in New York, California, Illinois, Maine, Massachusetts, France, Mexico, Brazil, Poland., North Carolina, Utah, Virginia, and China. The company has a geographical presence in India, China, Poland, Germany, France, Turkey, UAE, South Africa, and others. Some of the company’s subsidiaries are Axygen Bioscience, Inc. (U.S.), Corning Life Sciences (Wujiang) Co., Ltd. (China), Corning Japan K.K. (Japan), Corning GmbH (Germany), Corning B.V. (Netherlands), Corning Pharmaceutical Glass, LLC (U.S.), and Corning SAS (France).

Meticulous Research in its latest publication on Pharmaceutical Packaging Market has predicted the growth of 7.6% during the forecast year 2024-2031.

Schott Pharma AG & Co. KGaA (Germany)

Established in 2022 and headquartered in Mainz, Germany, SCHOTT Pharma AG & Co. KGaA was established as an independent subsidiary of Schott AG following the separation of its pharmaceutical Systems business unit. Schott Pharma AG & Co. KGaA manufactures drug containment and drug delivery systems, collaborates with other industry leaders, and offers syringes, cartridges, vials, and ampoules for the pharmaceutical market.

The company operates through two reportable segments, namely, Drug Containment Solutions (DCS) and Drug Delivery Systems (DSS). The company offers pharmaceutical packaging products from both these segments. The company has 16 manufacturing locations globally. The company has R&D centers in China, Germany, and Switzerland and analysis laboratories across the U.S. and Germany. The company has a geographical presence in the U.S., Switzerland, France, Italy, Mexico, Brazil, Argentina, Indonesia, China, India, and other countries.

Berry Global Group, Inc. (U.S.)

Founded in 1967 and headquartered in Indiana, U.S., Berry Global Group, Inc. is involved in the manufacturing and supply of rigid, flexible, and non-woven products. The company offers products for the healthcare, personal care, home care, hygiene, agriculture, animal & pet care, and food and beverage sectors. The company operates through four reporting segments, namely, Consumer Packaging International, Consumer Packaging North America, Engineered Materials, and Health, Hygiene & Specialties. The company offers pharmaceutical packaging products through the Consumer Packaging International and Consumer Packaging North America segments.

The company has more than 250 facilities across the globe, with a geographical presence in the U.K., Brazil, Canada, France, Netherlands, Spain, China, Thailand, India, and other countries. The company has 40 design & innovation centers. The company has 112 manufacturing facilities in the U.S. and Canada, 110 in Europe, and 36 in other parts of the world.

SGD Pharma (France)

Founded in 1896 and headquartered in Paris, France, SGD Pharma is a manufacturer of glass pharmaceutical packaging. The company provides primary packaging, including vials, ampoules, bottles, and droppers in Type I, II, and III glass, along with internal siliconization or protective plastic coatings. The company’s offerings are categorized into Ampoules, Vials Type I, Injectable Vials, Infusions, Oral, Nasal, Healthcare, Beauty & Care, and SGD Pharma Plus.

The company has five plants, seven furnaces, one sorting facility, and one decoration workshop, along with 90 agents and distributors and ten sales offices worldwide. Saint-Quentin-Lamotte Plant (France), Kipfenberg (Germany), Vemula (India), Zhanjiang (China), and Sucy-en-Brie (France) are the Production sites of SGD Pharma. The company has a global production capacity of more than 8 million vials per day.

SGD pharma is ISO 15378 certified along with ISO 9001 for Good manufacturing practices. Five production sites of SGD Pharma are ISO 45001 (standard for health and safety at work), ISO 14001 (a standard that specifies requirements for an effective environmental management system) certified, and four sites are ISO 50001 (standard for energy management)

Catalent, Inc. (U.S.)

Founded in 2007 and headquartered in New Jersey, U.S., Catalent, Inc. is involved in the development and manufacturing of solutions for cell and gene therapies, drugs, protein-based biologics, vaccines, and consumer health products. The company provides injectable, oral, and respiratory delivery technologies, along with protein, plasmid, viral, and cell gene therapy. The company offers products for the pharmaceutical, biopharmaceutical, and consumer health industries. The company operates through two reportable segments: Biologics and Pharma & Consumer Health, which encompass its Pharmaceutical Packaging offerings.

In February 2024, Novo Holdings (Denmark) acquired Catalent, Inc. for USD 16.5 billion. The company has 52 manufacturing facilities across Europe, Asia-Pacific, Latin America, and North America. The company has a geographical presence in Argentina, Brazil, the U.K., Italy, China, Japan, Singapore, and other countries.

Some of the company’s subsidiaries are Catalent Dusseldorf Gmbh (Germany), Catalent Japan K.K. (Japan), Catalent Nottingham Limited (U.K.), Catalent Pharmaceutical Technology (Shanghai) Co., Ltd. (China), Catalent Anagni S.r.l. (Italy), Catalent Uruguay S.A. (Uruguay), and Catalent Ontario Limited (Canada).

WestRock Company (U.S.)

Founded in 2015 and headquartered in Georgia, U.S., WestRock designs and manufactures fiber-based packaging solutions. The company is formed with the merger of RockTenn (U.S.) and MeadWestvaco Corporation (U.S.). The company operates in the pharmaceutical packaging market through four reportable segments: Corrugated Packaging, Consumer Packaging, Global Paper, and Distribution. The company offers products to end users such as beverage, fresh food, healthcare, home, beauty, personal care, and retail companies.

The company has a geographical presence in Japan, Korea, Mexico, China, Brazil, and India. Some of the company’s subsidiaries are KapStone Paper and Packaging Corporation (U.S.), Multi Packaging Solutions Global Holdings Ltd (U.K), Multi Packaging Solutions Limited (U.K), WestRock Converting, LLC(U.S.), Stone Global Inc. (U.S.), WestRock RKT, LLC (U.S), WestRock Company of Canada Corp. (Canada), and WestRock Company of Canada Corp. (Luxembourg).

Popular Mention: Drug Plastics Group (U.S.), West Pharmaceutical Services, Inc. (U.S.), Nipro Corporation (Japan), UFLEX LIMITED (India), Ecobliss Pharmaceutical Packaging (Netherlands), Bormioli Pharma S.p.a. (Italy), Origin Pharma Packaging (U.K.), and others.

Authoritative Research on the Pharmaceutical Packaging Market – Global Opportunity Analysis and Industry Forecast (2024-2031)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.